Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
ZTS
ZOETIS INC.
NYSE
$73.68
▲ UP 0.97% (0.70)

KEY STATISTICS

Market Cap$30.60 B
52w High$149.75
52w Low$71.00
Dividend Yield2.69%
FrequencyQuarterly
P/E11.20
Volume3.77M
Shares Out.419.23M

COMPANY

LEADERSHIP

Kristin C. Peck
CHIEF EXECUTIVE
Kristin C. Peck

COMPENSATION 2026

Salary$1,300,000
Stock Awards$9,562,347
Incentive Plan Pay$2,730,000
All Other Comp.$426,913
Total$17,206,760

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 1, 2013
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
14,500

PRICE TARGET

Target High$95.00
Target Low$80.00
Target Median$85.00
Target Consensus$87.33

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$2.29B
NOV
3
TUE

PRICE

$73.68 ▲ UP 0.97% (+$0.70)
$73.60$74.00$74.40$74.809:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM73.68

About Zoetis Inc.

https://www.zoetis.com ↗

Zoetis develops and sells animal health medicines, vaccines, diagnostics, and related products for livestock and pets worldwide, serving veterinarians, producers, and distributors since 1952.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ZOETIS INC. IS KNOWN FOR

Simparica Trio
Simparica Trio

A monthly chewable for dogs combines three active ingredients to protect against heartworm, ticks, fleas, roundworms, and hookworms, driving Zoetis' growth in the high-value companion animal market.

COMPETITORS

COMPETITOR
ELAN COMPARE
IDXX COMPARE
MRK COMPARE
PAHC COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1,050
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.04% · 12.0M
IHVV.AX
0.05% · 5.4M
SPY
0.05% · 5.2M
MOAT
1.77% · 2.8M
RSP
0.17% · 2.3M
VFLO
1.10% · 1.7M
VIRS
2.07% · 1.6M
FLGA.TO
0.35% · 1.1M
6TVM.DE
0.11% · 489.2K
SCHX
0.04% · 446.1K
DUHP
0.22% · 375.9K
XDEW.L
0.17% · 375.6K
DGRW
0.16% · 373.5K
FXH
1.68% · 260.0K
DSTL
0.76% · 219.6K
JQUA
0.18% · 216.5K
FMDE
0.19% · 215.9K
RECS
0.26% · 212.2K
KAT
2.10% · 190.3K
SM
SMRI
1.61% · 156.2K
XZ
XZME.F
0.11% · 143.4K
WSRUS.SW
0.14% · 131.7K
GSLC
0.06% · 131.6K
ZSP.TO
0.05% · 129.9K
PB
PBPH
0.70% · 96.6K
H4ZJ.DE
0.04% · 94.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
60.96%
HOLDERS
2,623
TOP 12 OF 2,623 · RANKED BY POSITION SIZE
Vanguard Group Inc
47.8M sh · $6.01B
Blackrock, Inc.
39.4M sh · $2.83B
Blackrock Inc.
36.8M sh · $6.39B
J. Stern & Co. Llp
24.1M sh · $24.07M
State Street Corp
19.8M sh · $2.49B
Morgan Stanley
16.9M sh · $2.48B
State Farm Mutual Automobile Insurance Co
15.9M sh · $1.14B
Blackrock Institutional Trust Company, N.A.
13.5M sh · $719.99M
Geode Capital Management, LLC
13.3M sh · $951.79M
Wellington Management Group Llp
11.4M sh · $1.43B
Blackrock Fund Advisors
9.2M sh · $490.23M
Polen Capital Management LLC
7.5M sh · $1.1B

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Ray Cisneros
Gilbert Ray Cisneros
Sale (Partial)
2026-07-16
 Ro Khanna
Ro Khanna
Purchase
2026-07-07
 Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-06-16
 Charles J. "Chuck" Fleischmann
Charles J. "Chuck" Fleischmann
Purchase
2026-06-09

INSIDER TRADES

★
OFFICER: EVP, CFO & COO
SACCARO JAMES
Purchase · 81.1K shares
2026-08-31
★
OFFICER: EVP, CFO & COO
SACCARO JAMES
— · —
2026-08-17
★
DIRECTOR
DAMELIO FRANK A
Sale · 6.7K shares
2026-08-07
★
OFFICER: EXECUTIVE VICE PRESIDENT
Nayak Abhay U
Purchase · 214 shares
2026-07-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
NEUTRAL 3
HOLD 2
OVERWEIGHT 2
OUTPERFORM 1
MARKET PERFORM 1
EQUAL WEIGHT 1
14 GRADES IN THE LAST 12 MONTHS
TD Cowen BUY Stifel HOLD BNP Paribas OUTPERFORM Citigroup BUY Piper Sandler NEUTRAL UBS NEUTRAL JP Morgan OVERWEIGHT William Blair MARKET PERFORM

SECTORS PEERS

PEERPRICE
ELV$423.71COMPARE
REGN$795.92COMPARE
CI$287.95COMPARE
COR$325.84COMPARE
ARGX$999.95COMPARE
TAK$18.66COMPARE
BDX$181.11COMPARE
HLN$9.40COMPARE